0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Breast Cancer
 121-140 of 767 Articles
JAMA | 
Review | 
Evan R. Myers, MD, MPH; Patricia Moorman, PhD; Jennifer M. Gierisch, PhD, MPH; et al.
JAMA. 2015;314(15):1615-1634. doi:10.1001/jama.2015.13183.
Includes: Supplemental Content

JAMA | 
Special Communication |  FREE
Kevin C. Oeffinger, MD; Elizabeth T. H. Fontham, MPH, DrPH; Ruth Etzioni, PhD; et al.
JAMA. 2015;314(15):1599-1614. doi:10.1001/jama.2015.12783.
Includes: CME, Supplemental Content

JAMA | 
Lab Reports | 
Tracy Hampton, PhD
JAMA. 2015;314(13):1331. doi:10.1001/jama.2015.11705.

JAMA Oncology | 
Original Investigation | 
Steven A. Narod, MD, FRCPC; Javaid Iqbal, MD; Vasily Giannakeas, MPH; et al.
JAMA Oncol. 2015;1(7):888-896. doi:10.1001/jamaoncol.2015.2510.
Includes: CME, Supplemental Content

JAMA Oncology | 
Invited Commentary | 
Elizabeth M. Swisher, MD
JAMA Oncol. 2015;1(7):951-952. doi:10.1001/jamaoncol.2015.2699.

JAMA Oncology | 
Original Investigation |  Open Access
Andrea Desmond, BS; Allison W. Kurian, MD, MSc; Michele Gabree, MS, CGC; et al.
JAMA Oncol. 2015;1(7):943-951. doi:10.1001/jamaoncol.2015.2690.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Laura Esserman, MD, MBA; Christina Yau, PhD
JAMA Oncol. 2015;1(7):881-883. doi:10.1001/jamaoncol.2015.2607.

JAMA Oncology | 
Viewpoint | 
Shoshana M. Rosenberg, ScD, MPH; Lisa A. Newman, MD, MPH; Ann H. Partridge, MD, MPH
JAMA Oncol. 2015;1(7):877-878. doi:10.1001/jamaoncol.2015.2112.

JAMA Oncology | 
Invited Commentary | 
Shyam K. Tanguturi, MD; Jennifer R. Bellon, MD
JAMA Oncol. 2015;1(7):941-942. doi:10.1001/jamaoncol.2015.2605.

JAMA Oncology | 
Original Investigation | 
Reshma Jagsi, MD, DPhil; Kent A. Griffith, MS; Thomas P. Boike, MD; et al.
JAMA Oncol. 2015;1(7):918-930. doi:10.1001/jamaoncol.2015.2590.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Simona F. Shaitelman, MD, MEd; Pamela J. Schlembach, MD; Isidora Arzu, MD, PhD; et al.
JAMA Oncol. 2015;1(7):931-941. doi:10.1001/jamaoncol.2015.2666.
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint | 
Donald A. Berry, PhD; Clifford A. Hudis, MD
JAMA Oncol. 2015;1(7):875-876. doi:10.1001/jamaoncol.2015.1293.

JAMA | 
Viewpoint | 
Steven J. Katz, MD, MPH; Allison W. Kurian, MD, MSc; Monica Morrow, MD
JAMA. 2015;314(10):997-998. doi:10.1001/jama.2015.8088.

JAMA Oncology | 
Invited Commentary | 
Kerri Winters-Stone, PhD
JAMA Oncol. 2015;1(6):776-777. doi:10.1001/jamaoncol.2015.2267.

JAMA Oncology | 
Original Investigation |  Open Access
Christine M. Friedenreich, PhD; Heather K. Neilson, MSc; Rachel O’Reilly, MSc; et al.
JAMA Oncol. 2015;1(6):766-776. doi:10.1001/jamaoncol.2015.2239.
Includes: Supplemental Content

JAMA Internal Medicine | 
Invited Commentary | 
Joann G. Elmore, MD, MPH; Ruth Etzioni, PhD
JAMA Intern Med. 2015;175(9):1490-1491. doi:10.1001/jamainternmed.2015.3056.

JAMA Internal Medicine | 
Original Investigation | 
Charles Harding, AB; Francesco Pompei, PhD; Dmitriy Burmistrov, PhD; et al.
JAMA Intern Med. 2015;175(9):1483-1489. doi:10.1001/jamainternmed.2015.3043.
Includes: CME, Supplemental Content

JAMA Internal Medicine | 
Viewpoint | 
Jennifer S. Haas, MD, MSc; Celia P. Kaplan, DrPH, MA
JAMA Intern Med. 2015;175(9):1439-1440. doi:10.1001/jamainternmed.2015.3040.

JAMA Otolaryngology–Head & Neck Surgery | 
Clinical Challenge | 
Christopher A. Burgess, FRCS; Neil M. Foden, MRCS; Stuart C. Winter, FRCS
JAMA Otolaryngol Head Neck Surg. 2015;141(9):845-846. doi:10.1001/jamaoto.2015.1412.

JAMA Oncology | 
From The JAMA Network |  FREE
Steven J. Katz, MD, MPH
JAMA Oncol. 2015;1(5):677-678. doi:10.1001/jamaoncol.2015.0764.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Oncology
Review  | 
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton, MD, PhD; Sylvia Adams, MD; Mary L. Disis, MD
JAMA Oncology
Original Investigation  | 
Trastuzumab-Related Cardiotoxic Effects in Taiwanese Women A Nationwide Cohort Study
Hsu-Chih Chien, MS; Yea-Huei Kao Yang, BSPharm; Jane P. F. Bai, AM, PhD